Regulation of skeletal muscle PPARδ mRNA expression in twins

Journal of Physiology

Volumn 584, Issue 3, 2007, Pages 1011-1017

  Nilsson, Emma ^a   Poulsen, Pernille ^a   Sjögren, Marketa ^b   Ling, Charlotte ^b   Ridderstråle, Martin ^b   Groop, Leif ^b   Vaag, Allan ^a  

^a STENO DIABETES CENTER   (Denmark)

^b LUND UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA;

ADULT; AEROBIC CAPACITY; AGE DISTRIBUTION; AGED; ARTICLE; BIOMETRY; BIRTH WEIGHT; CONTROLLED STUDY; CORRELATION ANALYSIS; DIZYGOTIC TWINS; ENVIRONMENTAL FACTOR; FEMALE; GENE EXPRESSION REGULATION; GLUCOSE METABOLISM; HEREDITY; HUMAN; HUMAN TISSUE; HYPERINSULINEMIA; LIPID METABOLISM; MALE; MONOZYGOTIC TWINS; MUSCLE BIOPSY; MUSCLE CELL; OBESITY; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; ABDOMINAL OBESITY; AGE; GENETIC REGULATION; LIPID ANALYSIS; OXIDATION; PPARDELTA GENE;

EID: 35648949329     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2007.140673     Document Type: Article

References (28)

1. Barker DJ, Eriksson JG, Forsen T & Osmond C (2002). Fetal origins of adult disease: Strength of effects and biological basis. Int J Epidemiol 31, 1235-1239.
2. Bring J & Wernroth L (1999). Inefficient analysis of twin data: Is there an association between diabetes and birth weight? Diabetologia 42, 898-899.
3. Cook JT, Levy JC, Page RC, Shaw JA, Hattersley AT & Turner RC (1993). Association of low birth weight with beta cell function in the adult first degree relatives of non-insulin dependent diabetic subjects. BMJ 306, 302-306.
4. Desai M, Crowther NJ, Ozanne SE, Lucas A & Hales CN (1996). Adult glucose and lipid metabolism may be programmed during fetal life. Biochem Soc Trans 23, 331-335.
5. Grace CJ, Swenne I, Kohn PG, Strain AJ & Milner RD (1990). Protein-energy malnutrition induces changes in insulin sensitivity. Diabetes Metab 16, 484-491.
6. Hales CN, Barker DJ, Clark PM, Cox LJ, Fall C, Osmond C & Winter PD (1991). Fetal and infant growth and impaired glucose tolerance at age 64. BMJ 303, 1019-1022.
7. Hofman PL, Cutfield WS, Robinson EM, Bergman RN, Menon RK, Sperling MA & Glucoman PD (1997). Insulin resistance in short children with intrauterine growth retardation. J Clin Endocrinol Metab 82, 402-406.
8. Holst D, Luquet S, Nogueira V, Kristiansen K, Leverve X & Grimaldi PA (2003). Nutritional regulation and role of peroxisome proliferator-activated receptor delta in fatty acid catabolism in skeletal muscle. Biochim Biophys Acta 1633, 43-50.
9. Hu C, Jia W, Fang O, Zhang R, Wang C, Lu J & Xiang K (2006). Peroxisome proliferator-activated receptor (PPAR) delta genetic polymorphism and its association with insulin resistance index and fasting plasma glucose concentrations in Chinese subjects. Diabet Med 23, 1307-1312.
10. Issemann I & Green S (1990). Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature 347, 709-710.
11. Krämer DK, Ahlsén M, Norrbom J, Jansson E, Hjeltnes N, Gustafsson T & Krook A (2006). Human skeletal muscle fibre type variations correlate with PPARα, PPARδ and PGC1α mRNA. Acta Physiol 188, 207-216.
12. Krämer DK, Al-Khalili L, Perrini S, Skogsberg J, Wretenberg P, Kannisto K, Wallberg-Henriksson H, Ehrenborg E, Zierath JR & Krook A (2005). Direct activation of glucose transport in primary human myotubes after activation of peroxisome proliferators-activated receptor delta. Diabetes 54, 1157-1163.
13. Ling C, Poulsen P, Carlsson E, Ridderstrale M, Almgren P, Wojtaszewski J, Beck-Nielsen H, Groop L & Vaag A (2004). Multiple environmental and genetic factors influence skeletal muscle PGC1a and PGC1β gene expression in twins. J Clin Invest 114, 1518-1526.
14. Ling C, Wegner L, Andersen G, Almgren P, Hansen T, Pedersen O, Groop L, Vaag A & Poulsen P (2007). Impact of the peroxisome proliferator activated receptor-α coactivator-1β (PGC-1 β) Ala203Pro polymorphism on in vivo metabolism, PGC-1 β expression and fibre type composition in human skeletal muscle. Diabetologia 50, 1615-1620.
15. Luquet S, Lopez-Soriano J, Holst D, Fredenrich A, Melki J, Rassoulzadegan M & Grimaldi PA (2003). Peroxisome proliferator-activated receptor delta controls muscle development and oxidative capability. FASEB J 17, 2299-2301.
16. Neale MC & Cardon LR (1992). Methodology for genetic studies of twins and families. Data summary, pp. 35-53. Kluwer Academic Publishers, Dordrecht, the Netherlands.
17. Patti ME, Butte AJ, Crunkhorn S, Cusi K, Berria R, Kashyap S et al. (2003). Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A 100, 8466-8471.
18. Petersen KF, Befroy D, Dufour S, Dziura J, Ariyan C, Rothman DL, DiPietro L, Cline GW & Shulman GI (2003). Mitochondrial dysfunction in the elderly: Possible role in insulin resistance. Science 300, 1140-1142.
19. Phillips DI, Barker DJ, Hales CN, Hirst S & Osmond C (1994). Thinness at birth and insulin resistance in adult life. Diabetologia 37, 150-154.
20. Poulsen P, Levin K, Beck-Nielsen H & Vaag A (2002). Age-dependent impact of zygosity and birth weight on insulin secretion and insulin action in twins. Diabetologia 45, 1649-1657.
21. Poulsen P, Levin K, Petersen I, Christensen K, Beck-Nielsen H & Vaag A (2005). Heritability of insulin secretion, peripheral and hepatic insulin action, and intracellular glucose partitioning in young and old Danish twins. Diabetes 54, 275-283.
22. Swenne I, Crace CJ & Milner RD (1987). Persistent impairment of insulin secretory response to glucose in adult rats after limited period of protein-calorie malnutrition early in life. Diabetes 36, 454-458.
23. Tanaka T, Yamamoto J, Iwasaki S, Asaba H, Hamura H, Ikeda Y et al. (2003). Activation of peroxisome proliferators-activated receptor delta induces fatty acid beta-oxidation in skeletal muscle and attenuates metabolic syndrome. Proc Natl Acad Sci U S A 100, 15924-15929.
24. Terada S, Wicke S, Holloszy JO & Han DH (2005). PPARδ activator GW-501516 has no acute effect on glucose transport in skeletal muscle. Am J Physiol Endocrinol Metab 290, E607-E611.
25. Vandenplas S, Wiid I, Grobler-Rabie A, Brebner K, Ricketts M, Wallis G, Bester A, Boyd C & Mathew C (1984). Blot hybridisation analysis of genomic DNA. J Med Genet 21, 164-172.
26. Vänttinen M, Nuutila P, Kuulasmaa T, Pihlajamaki J, Hallsten K, Virtanen KA, Lautamaki R, Peltoniemi P, Takala T, Viljanen AP, Knuuti J & Laakso M (2005). Single nucleotide polymorphisms in the peroxisome proliferator-activated receptor delta gene are associated with skeletal muscle glucose uptake. Diabetes 54, 3587-3591.
27. Wang Y-X, Lee CH, Tiep S, Yu RT, Ham J, Kang H & Evans RM (2003). Peroxisome-proliferator-activated receptor delta activates fat metabolism to prevent obesity. Cell 113, 159-170.
28. Wang Y-X, Zhang C-L, Yu RT, Cho HK, Nelson MC, Bayuga-Ocampo CR, Ham J, Kang H & Evans RM (2004). Regulation of muscle fibre type and running endurance by PPARδ. PLoS Biol 2, 1532-1539.